Clinical Trials
All Clinical Trials - Page 13 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06633783Phase 3Not Yet Recruiting
A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Semaglutide
- NCT07400783N/ARecruiting
TED_ORG: Study on Short Bowel Syndrome
Teduglutide
- NCT06644040Phase 1Completed
A Study of TeriQ Patch in Healthy Adult Female Participants
Teriparatide
- NCT06659744N/ACompleted
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
Semaglutide
- NCT06659718N/ACompleted
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Semaglutide
- NCT07553988Phase 2Active Not Recruiting
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
Gonadorelin
- NCT06649045Phase 3Active Not Recruiting
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Orforglipron
- NCT06643728Phase 2Active Not Recruiting
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Tirzepatide
- NCT06818292N/ACompleted
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
Liraglutide
- NCT06519656Phase 1/Phase 2Recruiting
Efficacy of Mazdutide for Treating PCOS
Mazdutide
- NCT06596135Phase 3Completed
Open-Label Extension Study of Setmelanotide
Setmelanotide
- NCT06642584Phase 1Completed
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
Semaglutide
- NCT06607926N/ANot Yet Recruiting
Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC
Thymosin-Alpha-1
- NCT06637189Phase 4Not Yet Recruiting
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
Gonadorelin
- NCT06888167N/ARecruiting
Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
Exenatide
- NCT06632444Phase 3Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Survodutide
- NCT06345079Phase 2Recruiting
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
Octreotide
- NCT06575738Phase 1Recruiting
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
Tirzepatide
- NCT06635057Phase 4Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Tirzepatide
- NCT06348264Phase 2Recruiting
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
Gonadorelin
- NCT06500143N/ACompleted
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
Semaglutide
- NCT07096063N/ACompleted
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
Tirzepatide
- NCT06606821Phase 4Recruiting
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Tirzepatide
- NCT07088718N/ACompleted
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
Tirzepatide
- NCT06564441Phase 1Completed
A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
Survodutide
- NCT05202353Phase 1Active Not Recruiting
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Semaglutide
- NCT06588283Phase 3Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Tirzepatide
- NCT06269120N/ACompleted
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Semaglutide
- NCT05663515N/ARecruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Exenatide
- NCT06640972Phase 2Completed
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
Tirzepatide
- NCT06396416Phase 4Recruiting
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Semaglutide
- NCT06588296Phase 3Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Tirzepatide
- NCT06634927Phase 1Completed
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
Semaglutide
- NCT06603571Phase 2Active Not Recruiting
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Tirzepatide
- NCT06604624Phase 3Completed
Semaglutide in Treatment of Obesity
Semaglutide
- NCT06380426N/ARecruiting
A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity
Semaglutide
- NCT06605703Phase 4Completed
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
Tirzepatide
- NCT06582446Phase 2Recruiting
Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)
Gonadorelin
- NCT06592261Phase 1Recruiting
Graded Insulin Suppression Test P&F
Octreotide
- NCT06485089N/ACompleted
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
Tirzepatide
- NCT06584916Phase 3Completed
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Orforglipron
- NCT06446531Phase 1Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk
Semaglutide
- NCT06484114N/AActive Not Recruiting
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
Tirzepatide
- NCT06557811Phase 4Not Yet Recruiting
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
Semaglutide
- NCT06573398Phase 2Not Yet Recruiting
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC
Thymosin-Alpha-1
- NCT06584006Phase 2Recruiting
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Thymosin-Alpha-1
- NCT06748638Phase 4Enrolling By Invitation
Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for Colonoscopy
Linaclotide
- NCT06449235Phase 4Unknown
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Semaglutide
- NCT06536023Phase 1Completed
This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
Mazdutide
- NCT06577090Phase 2Active Not Recruiting
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Semaglutide